AVTR
Avantor, Inc.
AVTR has a slight edge over UNH overall, supported by stronger valuation and stronger fundamentals.
UNH
UnitedHealth Group Incorporated
UNH has lower modeled downside risk, despite its lower overall score.
AVTR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
AVTR's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AVTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $15.62 | — |
| Cheap | 21x | $10.56 | -32% |
| Current | 31x | $15.62 | — |
| Fair | 41x | $20.70 | +33% |
| Expensive | 96x | $47.90 | +207% |
Historical ranges are pointers, not guarantees.
AVTR's PE is in its fair range at 31x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH has the edge over AVTR in the historical PE scenario, which offers more potential upside but is not a forecast.
AVTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
AVTR has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AVTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | +75% |
| Q3 2026 | $0.50 | +$0.63 |
| Q2 2026 | -$0.84 | -185% |
| Q1 2026 | -$0.81 | -178% |
| Q4 2025 | -$0.78 | -175% |
| Q3 2025 | -$0.13 | -129% |
| Q2 2025 | $0.99 | +87% |
| Q1 2025 | $1.04 | +174% |
| Q4 2024 | $1.04 | +121% |
AVTR has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
AVTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +4.6% |
| Q2 2026 | $1.7B | +0.5% |
| Q1 2026 | $1.6B | 0% |
| Q4 2025 | $1.7B | -1.4% |
| Q3 2025 | $1.6B | -5.3% |
| Q2 2025 | $1.7B | -1.1% |
| Q1 2025 | $1.6B | -5.9% |
| Q4 2024 | $1.7B | -2.1% |
AVTR's revenue has held roughly level: $1.7B last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +48 points |
| Q2 2026 | 7.2% | -0.5 points |
| Q1 2026 | 6.3% | -3 points |
| Q4 2025 | 7.6% | -30 points |
| Q3 2025 | -40% | -47 points |
| Q2 2025 | 7.7% | -2.7 points |
| Q1 2025 | 9.3% | +0.6 points |
| Q4 2024 | 38% | +27 points |
AVTR has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over AVTR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
AVTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $156.2M | -9% |
| Q2 2026 | $140.6M | +13% |
| Q1 2026 | $25.2M | -69% |
| Q4 2025 | $117.2M | -20% |
| Q3 2025 | $171.7M | -16% |
| Q2 2025 | $124.8M | -47% |
| Q1 2025 | $81.3M | -24% |
| Q4 2024 | $145.8M | -27% |
AVTR's free cash flow has been positive every quarter for seven years: $439M over the past year, down 16% from the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over AVTR on cash flow, with more consistent year-over-year improvement.
AVTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +3.7M shares |
| 1 year | -0.1% | -800K shares |
| 3 years | +0.4% | +2.4M shares |
| 5 years | +14% | +82.8M shares |
| Available history | +17% | +99.6M shares |
AVTR has 681M diluted shares, about the same as a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over AVTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
AVTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 28.9x | High |
| Q1 2026 | 29.1x | High |
| Q4 2025 | 21.8x | High |
| Q3 2025 | 5.4x | High |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | 2.6x | Moderate |
AVTR's net debt is about 3.5 years of its operating earnings (EBITDA), down from 5.4 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over AVTR on leverage, with a lower net debt burden relative to earnings.
AVTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.2 | Neutral |
| Stochastic | 62.4 | Neutral |
AVTR's weekly RSI is 64 (neutral) and its Stochastic is 62 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
AVTR PE vs Healthcare Sector
| Metric | AVTR | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 26x | 21% above |
| PE % | 33 | 29 | 4 pts above |
AVTR is trading at 31x earnings, a 21% premium to the Healthcare sector's median of 26x.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over AVTR on valuation relative to its sector.
AVTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.9 | 1.7% below |
| 20 week MA | $14.3 | 9.3% above |
| 50 week MA | $11.4 | 37% above |
| 100 week MA | $13.2 | 18% above |
| 200 week MA | $17.8 | 12% below |
AVTR's trend is mixed: it's above three of its five weekly moving averages, and 12% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over AVTR on trend strength, trading above more of its moving averages.
AVTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.2 | $27.1 | +49% |
| 2021 | $27.1 | $41.3 | +52% |
| 2022 | $41.3 | $20.5 | -50% |
| 2023 | $20.5 | $22.8 | +11% |
| 2024 | $22.8 | $21.4 | -6.2% |
| 2025 | $21.4 | $11.4 | -47% |
| 2026 YTD | $11.4 | $15.6 | +37% |
AVTR has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.